Case Control Study
Case Control Study
Second Edition
Case-Control Studies
Second Edition Authors:
Lorraine K. Alexander, DrPH
Brettania Lopes, MPH
Kristen Ricchetti-Masterson, MSPH
Karin B. Yeatts, PhD, MS
ERIC NOTEBOOK
PA G E 2
Controls
Exposed
Unexposed
No Disease
Exposed
n1
Unexposed
n2
RR = (a/n1)/(c/n2)
Case-Control Study
Cases
Controls
Exposed
Unexposed
*Note: Under some conditions, the odds ratio approximates a risk ratio or rate ratio. However, this is not
always the case, and care should be taken to interpret
odds ratios appropriately.
ERIC NOTEBOOK
case-control studies use prevalent cases while other casecontrol studies use incident cases. There are also different
ways that cases can be identified, such as using
population-based cases or hospital-based cases.
Types of cases used in case control studies
Prevalent cases are all persons who were existing cases of
the health outcome or disease during the observation
period. These studies yield a prevalence odds ratio, which
will be influenced by the incidence rate and survival or
migration out of the prevalence pool of cases, and thus
does not estimate the rate ratio. Case control studies can
also use incident cases, which are persons who newly
develop the health outcome or disease during the
observation period. Recall that prevalence is influenced by
both incidence and duration. Researchers that study
causes of disease typically prefer incident cases because
they are usually interested in factors that lead up to the
development of disease rather than factors that affect
duration.
Selecting controls
Selection of controls is usually the most difficult part of
conducting a case-control study. We will discuss 3 possible
ways to select controls:
1. Base or case-base sampling
2.
3.
PA G E 3
remained free of the health outcome at the end of followup then we call the sampling cumulative density sampling
or survivor sampling. Controls cannot ever have the
outcome (become cases) when using this type of
sampling. In these case-control studies, the odds ratio
estimates the rate ratio only if the health outcome is rare,
i.e. if the proportion of those with the health outcome
among each exposure group is less than 10% (requires
the rare disease assumption).
Incidence density sampling or risk set sampling
When cases are incident cases and when controls are
selected from the at-risk source population at the same
time as cases occur (controls must be eligible to become
a case if the health outcome develops in the control at a
later time during the period of observation) then we call
this type of sampling incidence density sampling or risk
set sampling. The control series provides an estimate of
the proportion of the total person-time for exposed and
unexposed cohorts in the source population. In these case
-control studies, the odds ratio estimates the rate ratio of
cohort studies, without assuming that the disease is rare
in the source population.
Note that it is possible, albeit rare, that a control selected
at a later time point could become a case during the
remaining time that the study is running. This differs from
case-control studies that use cumulative density sampling
or survivor sampling, which select their controls after the
conclusion of the study from among those individuals
remaining at risk.
Selecting controls in a risk set sampling or incidence
density sampling manner provides two advantages:
1. A direct estimate of the rate ratio is possible.
2. The estimates are not biased by differential loss to
follow up among the exposed vs. unexposed controls.
For example, if a large number of smokers left the source
population after a certain time point, they would not be
available for selection at the end of the study when
controls would be selected in a study that uses cumulative
density sampling or survivor sampling. This would give the
ERIC NOTEBOOK
PA G E 4
Sources of controls
ERIC NOTEBOOK
PA G E 5
Terminology
References
Acknowledgement
The authors of the Second Edition of the ERIC Notebook
would like to acknowledge the authors of t he
ERIC N ot ebook, First Edition: Michel Ib rahim ,
MD, PhD, Lorraine Alexander, DrPH, Carl Shy,
MD, DrPH, and Sherry Farr, GRA, Departm ent of
Epidem iology at t he Univers it y of N ort h Carolina
at Chapel Hill. The First Edition of the ERIC
N ot eb ook was produced b y t he Educat ional Arm
of the Epidem iologic Res earch and Inform at ion
Cent er at Durham, N C. The funding for the ERIC
N ot eb ook First Edit ion was provided b y t he
Departm ent of V et erans Affairs (DV A), V et erans
Healt h Adm inist rat ion (V HA), Cooperat ive
St udies Program (CSP) to prom ot e the s t rat egic
growt h of the epidemiologic capacit y of t he DV A.
ERIC NOTEBOOK
PA G E 6
Exposed
Unexposed
Cases
Controls
160 (a)
100 (b)
260
40 (c)
100 (d)
140
200
200
400